App-Quantinova.ai

Biosimilars switch in a multi-ethnic rheumatology patient group

Arumugam Moorthy - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

Infliximab

Efficacy of tocilizumab use in giant cell arteritis (GCA) and Takayasu arteritis (TA) patients allowing glucocorticoid dose reduction

Malinder Singh - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Large vessel vasculitis

Glucocorticoid

Assessing reasons for patients switching back from biosimilar etanercept therapy to originator product

Chanaka Dahanayake - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Etanercept

Retrospective audit of septic arthritis in Coventry and Warwickshire NHS Trust: 5-year data

Arani Vivekanantham - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Infectious arthritis

N/A

Annual review and health promotion for patients with spondyloarthritis: development of a pro forma and early implementation

Lesley Kay - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Spondyloarthritis

N/A

Predicting cirrhosis in methotrexate-treated patients: is elastography the answer?

Charelle Manning - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

sulphasalazine

Cutaneous leukocytoclastic vasculitis associated with golimumab

Mithun Chakravorty - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Leukocytoclastic vasculitis

golimumab

The management of coexisting systemic lupus erythematosus and axial spondyloarthritis with a combination of hydroxychloroquine and IL-17 inhibition

Tegwen Ecclestone - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Lupus

Hydroxychloroquine

A simple case of housemaid’s knee?

Ruth Smith - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Housemaid's knee

N/A

Hepatitis E as a cause of very abnormal liver function tests in patients attending rheumatology clinics: an emerging problem?

Robert D Sandler - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Hepatitis E virus infection

N/A

Cerebral toxoplasmosis in a RA patient receiving biologic therapy

Alina Sanda Gomez - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

Methotrexate

Henoch-Schönlein purpura following influenza vaccination in psoriatic arthritis patient

Abdul Khan - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Henoch-Schonlein purpura nephritis

Methotrexate

New onset of inflammatory polyarthritis shortly after commencing apixaban therapy

Thanuya Francis - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

apixaban

Use of PCR on joint fluid to diagnose Neisseria meningitidis associated arthritis in a patient with negative cultures

Susan S Wang - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Cogan syndrome: a rare vasculitis manifesting with rapid visual and hearing impairment

Rehan Asif - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Cogan syndrome

N/A

The right choice? Secukinumab in co-existing axial disease and multiple sclerosis

Arti Mahto - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Ankylosing spondylitis

secukinumab

Combining secukinumab and fingolimod to successfully treat ankylosing spondylitis and multiple sclerosis: a novel approach

Muhammad K Nisar - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Ankylosing spondylitis

secukinumab

Secukinumab and solid organ cancer: are they mutually exclusive?

Muhammad K Nisar - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Psoriatic arthritis

secukinumab

A case of pyrexia of unknown origin during pregnancy

Iman Ali - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Infective endocarditis

Methylprednisolone

Focal denervation myositis secondary to S1 radiculopathy: an uncommon cause of unilateral calf swelling

Sarah Loughrey - British Society for Rheumatology (BSR) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Myositis

N/A

Filters

45280 Abstracts